These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29953013)

  • 1. Efficacy of Yokukansankachimpihange on sleep disturbance in Parkinson's disease: A study protocol of a randomized, double blind, placebo-controlled pilot trial.
    Jang JH; Lee J; Jung I; Yoo H
    Medicine (Baltimore); 2018 Jun; 97(26):e11298. PubMed ID: 29953013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yokukansankachimpihange, a traditional Japanese (Kampo) medicine, enhances the adaptation to circadian rhythm disruption by increasing endogenous melatonin levels.
    Imamura S; Tabuchi M; Oizumi H; Ueki T; Omiya Y; Ikarashi Y; Mizoguchi K
    J Pharmacol Sci; 2020 Nov; 144(3):129-138. PubMed ID: 32921394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
    Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
    JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of SQJZ herbal mixtures on nonmotor symptoms in Parkinson disease patients: Protocol for a randomized, double-blind, placebo-controlled trial.
    Shi J; Tian J; Li T; Qin B; Fan D; Ni J; Wei M; Zhang X; Liu N; Liu J; Li Y; Liu W; Wang Y
    Medicine (Baltimore); 2017 Dec; 96(50):e8824. PubMed ID: 29390272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study.
    Pierantozzi M; Placidi F; Liguori C; Albanese M; Imbriani P; Marciani MG; Mercuri NB; Stanzione P; Stefani A
    Sleep Med; 2016 May; 21():140-4. PubMed ID: 27448485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial.
    Schrempf W; Fauser M; Wienecke M; Brown S; Maaß A; Ossig C; Otto K; Brandt MD; Löhle M; Schwanebeck U; Graehlert X; Reichmann H; Storch A
    Eur J Neurol; 2018 Apr; 25(4):672-679. PubMed ID: 29322594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial.
    Ahn JH; Kim M; Park S; Jang W; Park J; Oh E; Cho JW; Kim JS; Youn J
    Parkinsonism Relat Disord; 2020 Jun; 75():50-54. PubMed ID: 32480307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo formula for constipation in Parkinson disease.
    Jin Z; Liu Z; Kang L; Yang A; Zhao H; Yan X; Zhang T; Gao L; Liu A; Fang B
    Medicine (Baltimore); 2020 Jul; 99(28):e21145. PubMed ID: 32664145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of the Traditional Herbal Medicine, Gamiguibi-tang, in Patients With Cancer-Related Sleep Disturbance: A Prospective, Randomized, Wait-List-Controlled, Pilot Study.
    Lee JY; Oh HK; Ryu HS; Yoon SS; Eo W; Yoon SW
    Integr Cancer Ther; 2018 Jun; 17(2):524-530. PubMed ID: 29034740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Yokukansan and Yokukansankachimpihange on Aggressive Behavior, 5-HT Receptors and Arginine Vasopressin Expression in Social Isolation-Reared Mice.
    Iba H; Watanabe T; Matsuzawa K; Saimiya M; Tanaka M; Nagao M; Moriyama H; Kubota K; Katsurabayashi S; Iwasaki K
    Biol Pharm Bull; 2019; 42(12):2009-2015. PubMed ID: 31787717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.
    Chang YS; Lin MH; Lee JH; Lee PL; Dai YS; Chu KH; Sun C; Lin YT; Wang LC; Yu HH; Yang YH; Chen CA; Wan KS; Chiang BL
    JAMA Pediatr; 2016 Jan; 170(1):35-42. PubMed ID: 26569624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.
    Medeiros CA; Carvalhedo de Bruin PF; Lopes LA; Magalhães MC; de Lourdes Seabra M; de Bruin VM
    J Neurol; 2007 Apr; 254(4):459-64. PubMed ID: 17404779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study.
    De Cock VC; Dodet P; Leu-Semenescu S; Aerts C; Castelnovo G; Abril B; Drapier S; Olivet H; Corbillé AG; Leclair-Visonneau L; Sallansonnet-Froment M; Lebouteux M; Anheim M; Ruppert E; Vitello N; Eusebio A; Lambert I; Marques A; Fantini ML; Devos D; Monaca C; Benard-Serre N; Lacombe S; Vidailhet M; Arnulf I; Doulazmi M; Roze E
    Lancet Neurol; 2022 May; 21(5):428-437. PubMed ID: 35429481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
    Singer C; Tractenberg RE; Kaye J; Schafer K; Gamst A; Grundman M; Thomas R; Thal LJ;
    Sleep; 2003 Nov; 26(7):893-901. PubMed ID: 14655926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
    Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of suanzaoren decoction for chronic insomnia disorder in adults: study protocol for randomised, double-blind, double-dummy, placebo-controlled trial.
    Zhou QH; Wang HL; Zhou XL; Xu MB; Zhang HF; Huang LB; Zheng GQ; Lin Y
    BMJ Open; 2017 Apr; 7(4):e014280. PubMed ID: 28377394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial.
    Zeng C; Liu X; Hu L; Feng Y; Xia N; Zeng H; Luo L; Ye R; Yuan Z
    Trials; 2020 May; 21(1):408. PubMed ID: 32414414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert.
    Tabuchi M; Mizuno K; Mizoguchi K; Hattori T; Kase Y
    Front Pharmacol; 2017; 8():235. PubMed ID: 28491038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yokukansankachimpihange Improves the Social Isolation-Induced Sleep Disruption and Allopregnanolone Reduction in Mice.
    Murata K; Li F; Shinguchi K; Ogata M; Fujita N; Takahashi R
    Front Nutr; 2020; 7():8. PubMed ID: 32118027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.